Robust AI-ECG for Predicting Left Ventricular Systolic Dysfunction in Pediatric Congenital Heart Disease
Yuting Yang, Lorenzo Peracchio, Joshua Mayourian, John K. Triedman, Timothy Miller, William G. La Cava
TL;DR
AI-ECG for LVSD screening in pediatric CHD is impeded by limited data and privacy constraints. The authors propose a robust, architecture-agnostic framework combining on-manifold adversarial perturbations with uncertainty-aware adversarial training to focus learning on near-boundary, uncertain samples, with latent-space perturbations constrained by a pre-trained autoencoder (ViT-MAE). On a real-world pediatric dataset, the approach delivers robust LVSD detection and shows substantial gains under data-scarce conditions (e.g., 10% of data), especially for challenging subgroups such as pacemakers, as confirmed by comprehensive ablations. The method’s generality and performance uplift suggest practical deployment in data-limited hospitals and potential extension to multi-modal cardiac tasks to advance democratization of AI in pediatric cardiology.
Abstract
Artificial intelligence-enhanced electrocardiogram (AI-ECG) has shown promise as an inexpensive, ubiquitous, and non-invasive screening tool to detect left ventricular systolic dysfunction in pediatric congenital heart disease. However, current approaches rely heavily on large-scale labeled datasets, which poses a major obstacle to the democratization of AI in hospitals where only limited pediatric ECG data are available. In this work, we propose a robust training framework to improve AI-ECG performance under low-resource conditions. Specifically, we introduce an on-manifold adversarial perturbation strategy for pediatric ECGs to generate synthetic noise samples that better reflect real-world signal variations. Building on this, we develop an uncertainty-aware adversarial training algorithm that is architecture-agnostic and enhances model robustness. Evaluation on the real-world pediatric dataset demonstrates that our method enables low-cost and reliable detection of left ventricular systolic dysfunction, highlighting its potential for deployment in resource-limited clinical settings.
